Yazar "Jafarzade, A." seçeneğine göre listele

Listeleniyor 1 - 1 / 1
  • Küçük Resim Yok
    Öğe
    Can M-30, M-65, and IL-6 serum levels be useful markers in the diagnosis of preeclampsia and gestational diabetes?
    (Verduci Publisher, 2023) Jafarzade, A.; Bulut, B.; Bulut, H.; Mihmanli, V.
    - OBJECTIVE: We aimed to evaluate the maternal and fetal serum M-30, M-65 and IL -6 levels in preeclampsia and gestational diabetes mellitus (GDM) in both maternal and cord blood. PATIENTS AND METHODS: Women with pre-eclampsia (n=30), GDM (n=30), and uncomplicated pregnancy (n=28) were evaluated in a cross-sec-tional study. After clamping during delivery, the serum M-30, M-65, and IL-6 levels were measured in both maternal venous blood and cord blood.RESULTS: The serum M-30, M-65, and IL-6 levels were significantly higher in preeclampsia and GDM patients' maternal blood and cord blood samples compared to the control group. In the preeclampsia group, M-65 was significantly high-er in cord blood compared with the level in mater -nal serum, but there was no significant difference between the GDM and control groups. The con-trol group's IL-6 level in cord blood was statisti-cally significantly lower than the other groups. Al-though the M-30 value in both maternal and cord blood was statistically lower in the control group than in the GDM group, there was no significant difference between the two groups when com-pared to the preeclampsia group.CONCLUSIONS: M-30 and M-65 molecules appear to have the potential to serve as bio-chemical markers in placental diseases, partic-ularly preeclampsia and gestational diabetes. Due to the insufficient sample sizes, more re-search is needed.